Author: Biocytogen Boston

Biocytogen Opens San Francisco Office to Accelerate Globalization

May 31, 2023

Beijing, China and San Francisco, CA, May 31, 2023 – Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) has announced the opening of a new office in San Francisco, California, USA. The new space will aim to accelerate the globalization of Biocytogen’s businesses. San Francisco is renowned as a hub of the biotechnology industry, and […]

Read More

Biocytogen to Present Pipeline Assets and R&D Progress at BIO International Convention, June 5-8, 2023

May 24, 2023

Biocytogen’s antibody BD and licensing (BDL) team will be delivering an oral presentation on Monday, June 5th at the 2023 BIO International Convention in Boston, taking place from June 5-8. The presentation will highlight Biocytogen’s clinical and preclinical pipeline assets, 6 fully human antibody discovery platforms, as well as the progress of Project Integrum, an […]

Read More

Meet Biocytogen’s APAC Business Development Team at 70th JALAS 2023!

May 19, 2023

Biocytogen’s Asia-Pacific business development team is pleased to exhibit at the 70th Japanese Association for Laboratory Animal Science (JALAS) annual meeting from May 24-26, 2023 in Tsukuba, Japan! Join us at Booth D-3 to learn more about how BioMice models and services, our fully human antibody discovery platforms and antibody assets can help you develop […]

Read More

May 2023 Newsletter

May 10, 2023

New Animal Models Humanized Immune-Checkpoint Mice Catalog Number Product 112657 B-hCD19 Mice 110888 B-hCD30 Mice 111141 B-hCD48 Mice 111257 B-hCX3CL1 Mice 112105 B-hICOS Mice 110904 B-hNOTCH1 Mice 112801 B-hPD-1/h4-1BB/hB7-H4 Mice 112791 B-hPD-1/hTIGIT/hVEGFR2 Mice Humanized Cytokine Mice Catalog Number Product 111594 B-hADIPOQ Mice 111396 B-hCCL24 Mice 111092 B-hGHRL Mice 111871 B-hIL10RA/hIL10RB Mice 111995 B-hIL20 Mice 111889 […]

Read More

Join us at PEGSBoston: May 15-19

Date: May 15-19
Location: Boston

Join us in our luncheon presentation and meet with our team at booth #9 in PEGS Boston from May 15-19 ! Learn more about our antibody discovery services and other platforms to help support your research projects. Luncheon Session: Tuesday, May 16th, 12:40 PM Speaker: Dr. Qingcong Lin, CEO, Biocytogen Boston Session Title: RenNano: A […]

Read More

Join us at ASGCT2023: May 16-20

May 8, 2023

  Join us at booth #574 at American Society of Gene & Cell Therapy Annual Meeting 2023 from May 16-20 in Los Angeles, CA! Learn more about our custom model generation services and pharmacology services to support your therapeutic discovery and preclinical validation. Attend the meeting Talk to us at the booth 574! The American […]

Read More

Meet Biocytogen’s Business Development Team at BIO KOREA 2023!

May 8, 2023

Biocytogen’s business development team is pleased to exhibit and host 1-on-1 meetings at BIO KOREA 2023, taking place from May 10-12, 2023 in Seoul, South Korea. Join us at booth C5 to learn more about our 6 proprietary fully human antibody discovery RenMiceTM platforms: monoclonal antibody (RenMabTM), bispecific antibody and bispecific ADC (RenLite®), nanobody (RenNano®), TCR-mimic antibody for intracellular targets […]

Read More

Immune system-reconstituted models for immuno-oncology research: Applications of humanized B-NDG mice engrafted with CD34+ HSCs

May 5, 2023

Introduction: Choosing the right humanized model for your study The relative success of immuno-oncology drugs has directed research toward discovering novel targets and therapeutic agents. This has also resulted in heightened demands for the establishment and utilization of relevant, robust animal models for in vivo evaluation of novel preclinical drug candidates.With the shift toward multitargeted […]

Read More

Webinar: Joint, Lung, and Urinary Disease Models Offered at Biocytogen

May 3, 2023

Our webinar “Joint, Lung, and Urinary Disease Models Offered at Biocytogen” was live at 1:00 PM EDT on May 25th, 2023.  About the Webinar Inflammatory disease models are important preclinical research tools to study disease pathogenesis and uncover novel treatments. To directly evaluate the efficacy and safety of therapeutic drug candidates targeting these disorders, we can […]

Read More

Join us at Immunology 2023: May 11-15

April 26, 2023

Join us at booth #4097 at Immunology 2023 from May 11-15 in Washington. D.C! Learn more about our custom model generation services and other platforms to help support your research projects. Attend the meeting Talk to us at the booth 4097! With major lectures from some of the world’s most prominent immunologists, and podium and […]

Read More

Back to top